EP4398899A1 - THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL, A P-GP INHIBITOR, AND A CHECKPOINT INHIBITOR FOR THE TREATMENT OF SOLID TUMORS